 Hey Wayne, how are you? Great, thanks. How are you doing? I'm fantastic. Thank you for joining us. Thank you for having me. Well, we're live right now and we're excited to speak with you today and you guys had another strong day today. Congratulations. Thanks. Yeah, it's been a great couple days. Yeah, and you guys have lots of big news. Let's talk a little bit about TraceSafe's strategic focus on enterprises with over 1,000 employees. How big is the market opportunity and what regions do you see the most demand, Asia, Europe or North America? Well, I think the, you know, if you think about a sort of pandemic focus just in the near term and where things are moving, it seems like the Asia region is a little bit further ahead in general. And so we've been seeing a lot of pickup. We did a, you know, tier one semiconductor manufacturer that has operations all over the world. But, you know, that supply chain primarily centered in the Asia region. And, you know, that was a big story around making sure that the employees in various regions can move around and between different manufacturing facilities. And I think there's the story around having, you know, more than 1,000 employees means you typically are spread out geographically. You probably have to comply with multiple different health standards and need to be complying with the highest health standards as a general rule. Now, they also tend to have budget around solving these problems. And that can lead into the next phase of our growth, which is going to be after we've deployed wearables into these environments, you know, what are the solution verticals we can, we can start going after that will make those wearables sticky in the future and what kind of products can we build around those? I love what you guys are doing. It's really exciting. And it seems as though you guys have just huge news coming out consistently with huge partnerships, huge clients. I was talking to a friend of mine that was predicting that you guys were going to be coming to Canada. And I'm not sure you can say anything about it, but the government of Canada was saying that they're looking to do contact tracing. They want to do better, more effective contact tracing. Right away, TraceSafe came to mind and I'm sitting here thinking, wow, that'd be pretty wild if you had a government contract with the Canadian government. And obviously you probably can't speak on that until it's public. But is that the type of thing you're working on these types of government contracts? Because when I see these types of deals with 1000 employees, that tells me you guys are going after only huge businesses. You're going after the biggest companies. You don't want to focus on the smaller businesses. That's exciting for an investor when you think about the scalability of TraceSafe. It's pretty wild what you guys are working on here. Yeah, I mean, really, we've been working on, you know, we've taken a lot of these pilot projects that have been happening in the background for many, many months and really working on scaling those up. Just in the last little bit, we saw the Canadian government went a different direction as far as policy, having a mandatory hotel quarantine. Our solution has worked really well in other jurisdictions where they didn't necessarily do the hotel quarantine, but they wanted to make sure that it was hotel-like. So in the event that the Canadian government makes a policy shift or offers alternatives, we would be, I think, the number one consideration given the number of countries that we've been working on thus far. That's what I was thinking, because when I heard that they were going in that direction, the only company that came to mind was TraceSafe. And I thought, wow, how many other governments are thinking about this and what other options are out there? I don't see any better options than TraceSafe. Now, I have another question for you. TraceSafe has a number of pilot programs for different customers. When do you see these scaling up? We see a lot of these programs maturing in actually more interesting ways than we imagined. So one of the things that we're seeing is that if you land in a pilot project as a contact tracing or a very simple one-dimensional solution, and once you get the product there, it becomes apparent that the product might be useful where they thought it was only useful for column A. You see that column B, C, D, and E are areas that we might also be able to make a big impact in. So what we're seeing is pilot projects are not just leading to orders, but they're also leading to broader technology discussions. Over and over, we're seeing that the case is that there's a solution where you think you need a wearable for a very small problem set, but actually the applicability is very wide and the benefit is really great. They see it solving a lot more problems. So the same investment that they would be making to solve one problem, they can make that investment and solve many, many problems. And for us, it makes a lot more sense because we get to participate from a software revenue perspective for a lot longer in those situations. So we see that the pilot programs themselves are maturing and they're all maturing and we're starting to release the news about those, about those programs. And they're getting, the mandates are becoming a lot broader. Wayne, can you talk about how TraceSafe's growing scale as a platform and how it plans to monetize its users in the future? Yeah, so the scale is really our major advantage. And having done this since it was really a MedTech-focused company, I think the, how we plan to monetize in the future, we've talked a lot about our mix of revenue and the fact that especially early days when we were servicing just those government clients, there's a lot of hardware revenue in the mix. And so it's basically 80% of hardware and 20% software. And as we move forward, more of that revenue and more of those monetization opportunities are emerging as software opportunities. So that means, whether it's just how the customer wants to be billed or whether it's building custom solutions, it's really becoming a software and SaaS-focused business. And so we're moving, we're getting towards, you know, a lot of our contracts, we're getting towards more of a 50-50 revenue split there. And as we kind of, you know, as the opportunity set widens up as far as what we can do with the technology. And that means, you know, connecting with assets on the sites, connecting kind of different, different feature sets that the customer's looking for, those become billable software opportunities. Wayne, how does Traceafe differentiate itself from competitors? And what's your competitive advantage? I think the main competitive advantage is this company has products that work. You know, the engineering is done right at a silicon level, you know, all the embedded systems and everything. The product is much more efficient, you know, on average than competitive products. And so, you know, it tends to manifest itself in just a lighter, you know, you have a more efficient product, you need a smaller battery to do the same thing, you have a lighter, better feeling product. So that means we can build the product into different form factors that kind of become invisible to the user. And so that's really what it is. Our products are more tightly integrated. The software, the hardware and everything else is very tightly integrated. It's much more efficient. Battery life is much longer, and it results in actually a better wearable. You know, if there's one watch and it's very, very heavy, and there's one watch that's sort of light as a feather, you know, you're going to prefer the one that's a little bit lighter, especially if it's in an enterprise environment, you know, it's in a workplace environment where those things matter. So that's our competitive advantage. I think the other competitive advantage is our ability to scale horizontally. So, you know, a company like where we're deploying 60,000 wearables, you know, our systems can handle that sort of thing, where a lot of these contact tracing companies that are just kind of born out of the need for contact tracing specifically, you know, they don't have the scalability and systems to kind of bring that up to that level. I'm a huge sports fan. I love what you guys are doing with sports. 2020 was one of the most disturbing years of my life watching sport after sport be canceled. And just like even now, watching sports with no fans is just weird. It doesn't matter if it's UFC, it doesn't matter if it's Major League Baseball, NFL, NBA, NHL, it's not the same. Okay. And 2020 had a lot of sports get canceled because of this COVID. How does 2021 look different? Thanks to Trey Safe and what you're bringing to the table and how you're helping sports venues. How are you guys making the difference? Because now we see NHL is ongoing, NBA is ongoing, UFC is ongoing, and they don't plan to shut down again. They just want to continue to move forward. How are you guys helping that? So we're working on a number of initiatives around kind of these mass gathering sporting events and figuring out how to bring in systems that scale up and get people back into the stadiums. So I think that, you know, the way the conversations that we're hearing from these sport organizations, stadium owners and health offices is that they want to get, you know, kind of the season ticket holders back in and you're seeing that a little bit in a few stadiums. And so we're slowly building systems that can kind of get that number there. Then you sort of, you're on a plateau and you can understand how that's interacting and working well. And then you can kind of move to the next plateau. And so we want to be able to show that we're able to bring fans in back into the stadium at varying levels of, you know, increasing density in a safe manner and put systems in place that enable that. And I think also at the same time, what you want to do is you want to elevate the fan experience. And that's really what you can accomplish with wearables that it's not like the idea is not to get people into a stadium wearing some sort of safety thing. Like they feel like they're going to be on a boat wearing a life jacket or something like that. Like we don't want something that's going to damper the fan experience. We want something that's going to enhance it. And wearables, you know, are a major way to enhance an experience, whether that's, you know, seamless payments inside of a venue, whether it's, you know, different VIP experiences and access. You know, there's lots of ways to do that. And we're working with these venue owners, these sports teams, concerts, et cetera, to make that happen and really elevate the experience. That would be pretty cool. Like would you, I'm a huge Toronto Maple Leafs fan, would you have like a wearable with like the Toronto Maple Leafs logo on it or something? So that people would feel like an affinity to it. Oh yeah, look, I got my wearable, my trace safe Maple Leafs logo on my wrist. Little things like that go a long way with the customers. That's exactly right. I mean, you know, and people, you know, the same way people wear jerseys and everything like that. And there's differences between, you know, there's difference between, you know, certain jerseys you can bet only a fan can tell the difference, right? You know, true the true, the true fans. And so, you know, the same thing is going to be going to be true with the wearables. We see that as, as a great thing. All premier facilities, I think, will really embrace this. You know, this is something that you see more at the high end. Disneyland was famous for introducing the Magic Band a few years back. And that was something that really was like a VIP experience. You go in, you get the Magic Band. It's something that gives you priority access on the rides. It interacts with the food and beverage services. It really kind of enhances your, your, your park experience. And it's like another level, you know, above. And we see that the same thing with, with the venues we're talking to. It's really about a premium fan experience and bringing that. And really, you have to start with the core sort of safety and commercial considerations, which we're doing, and then you build on top of that. And it's the same in the enterprise world. You know, you start with these core commercial considerations of business continuity, keeping the operations going and keeping people feeling safe. And then you build additional services on top of that. So that's really the, the whole story is, is starting, you know, that you have this pandemic. It's a major catalyst. And then, you know, it's, it's the next chapters that you write after that. I have a question from the audience. A lot of promise in the healthcare area with diabetes on the rise. How will TraceSafe capitalize on these problems? If, if at all? Well, it's interesting. In the healthcare sector, we're seeing a whole different segment of problem emerge, which is that, you know, hospitals, you know, hospitals can become really crowded, busy places. So actually in Singapore, we developed a system and product set to test at one of the largest hospitals in the country that was really centered around making sure that outpatients who are coming in for checkups didn't have to just spend a lot of time and have potential exposures to COVID and other things inside the hospital. And we all know the experience of being in a hospital and having to just wait endlessly and not knowing when, when, when you're going to be there. And a lot of the time you're just essentially sitting in a waiting room. And, you know, hospitals tend to have coffee shops and other places for you to go and be, if you know, you're going to have a long wait. But how do you communicate that to people? So this particular hospital, they've got a wearable, you get, you get to the hospital, you get the wearable. And then it essentially tells you when and how to get to your appointment exactly when you need to be there so that there's zero wait time when it comes to that. And so zero wait times, while it might not be something that directly impacts the, you know, the health and well-being in the example of the question was around diabetes, but affecting the overall efficiency of a hospital is something where, you know, the entire community health can be impacted by that because you can see more patients, you know, doctors that, you know, don't have the stress necessarily of being kind of having a pile up going on. So really bringing that efficiency to the hospitals, that's a, that's something that benefits at a much more macro scale. And that's one of the areas we're helping in healthcare. When we had you on our show last time, the stock was around 70 cents. Today you're around $1.75. So it's gone up a dollar in a very short period of time. And a lot of our investors are very excited about that. A lot of them are very happy about it. Some of them are frustrated that they missed the opportunity. Some of them might have sold too soon and now they see the stock going higher. For someone that is learning about Trace-A for the first time, maybe hasn't invested in your company yet, just learning about it for the first time today, what's your message to those people? What's your message to investors that are learning maybe today for the first time about Trace-Safe? Well, what I would say that I think that there is a bit of a disconnect is that, you know, you saw our announcement around, you know, a 60,000 person deployment. I think what people don't see in the background is how much time and effort actually goes into making one of those. We, you know, I don't think they keep records or scores on these sort of things, but I would be very surprised if there was ever a larger wearables order in corporate history than that 60,000 unit one that we deployed. And so that takes a lot of energy and efficiency when it comes to supply chain from logistics, from the operation standpoint of just deploying and, you know, the touching and sort of understanding of the kind of emerging issues that come up as you deploy at that scale. So these are huge coordination problems and they're things that spool up over a long time period beforehand. So you're seeing in a news release that comes out, you know, last week, you're seeing the fruits of labor that's really been months and months and months in the making and we're working on many, many, many different deals like that in the background constantly that obviously we can't talk about until their material and their sign and they're actually we're shipping the product. So I would say that, you know, although we see that deal come out, you know, you're not seeing all of the legwork and sort of the effort that's going into the next wave of news that we'll be talking about, you know, in the coming weeks and months. And so I would say that's the big thing that I think people see, okay, you know, they think that when we get some news out that that's when the work starts, but really the team has been busy working on that and executing on those deals a lot of times for months prior to them being announceable. So I think that would be that would be one thing. And so I think that people are right to be excited about the opportunities that we've been able to execute so far. And we're going to continue to deliver. And we have a lot of amazing stuff in the pipeline. Now, one question that I just that just came up in my head is you guys, I've really been like you're up 600% since November. So the stock is just going crazy. For good reason, you guys have a great disruptive product that could potentially save lives all over the world, get people back to sports, get the world back to normal. This is not just a want this is a need right now in 2021. So knowing that, what's the upside now for an investor? Are you thinking about, hey, wait a second, we've gone up $1 in a couple of weeks, we're up 600% in a couple months. Maybe now are you starting to think about maybe a NASDAQ listing or a New York stock exchange listing? Is it too soon to think about that? Or is that something that maybe you're thinking about? Because that would create massive exposure for your company. Just put you guys on a completely another level. Yeah, I think the first stopover point is I believe we need to get to a $2 US price to consider. There's a NYC AMAX listing that we can consider at that point. And we've been starting those discussions. That's definitely an area we've been thinking about. I know our directors and leadership are always thinking about ways to make sure that the shareholder value is being realized. And I think at the market cap we're at, it's still very much day one. I mean, you do have those big percentage moves, but I think in absolute terms, the company is still very much a very small microcap company. And when you consider the opportunities and the customer wins they're getting, it would be surprising if it stayed a microcap for very long. It's really the company is maturing, the story is maturing. People are finally, there's two things that are really happening. People are realizing there's a narrative out there which was, I would say in the latter half of 2020 is that we're just two more weeks out of this pandemic. We're just two more weeks and we're just perpetually two weeks away from resolution. And I think in 2021 people are starting to feel like, okay, well, we're going to figure out, there is a very much an end to this, but we're going to figure out how we solve it along the way. And Traceafe is really becoming a part of that solution. Canada didn't impose any sort of inbound traveler quarantine program until 2021. So that just tells you where we're at. Whereas you look at a country like Hong Kong, they instituted an inbound traveler quarantine program in February and March of 2020. So we are a bit of a time lag. We will get a handle on this. I'm very much an optimist when it comes to this because the story around Traceafe and wearables is so much more bullish post pandemic. Having wearables deployed in the enterprise, it's such a position of advantage to play from that we can't wait for that to happen. And we think that we have a lot of time to continue the deployment story and really get some of those next next generation products together, which we're already working on and working with customers to address some of those things. I mean, these are going to be very mind-blowing things. You can see a lot of our company in the near future. Yeah, I'm so excited to see what you guys have in store next. Congratulations on all your success. Hopefully the next time you come on our show, you guys go up at least another dollar. Every time you come on the show, you guys go up a dollar. That would be fantastic. Super proud of what you guys are doing, not just as far as the stock is concerned, but on a humanitarian level. I love what you guys are doing. You're not just focused on making money, but you're making a difference. And because of that, that's why I believe this will be a huge success story. And it already has been. Congratulations on all your success, Wayne. And I hope you continue to achieve all of your objectives that you set forth for yourself and for your company. Guys, thank you guys for watching. Remember, Rich TV Live is strictly for education and entertainment purposes. Always do your due diligence. Always do your research before you invest in anything that we talk about here in Rich TV Live. If you liked the video, smash the like button, comment down below, share the video everywhere, and subscribe. Take a look at and put Traysafe, TSF on your watch list, put it on your radar, U-T-O-L-F in America, TSF in Canada. Thank you, Wayne, for joining us and hope to have you again on the show soon. Thanks so much for everything. Thank you for watching. Those of you guys that are watching, if you're not winning, you're not watching. We bring in the winners and we bring them to you first. We brought you Traysafe at 70 cents, today at $1.75. Congratulations to everybody. And I think the story is just beginning to be told. Have a nice day, everyone. Thank you, Wayne. Have a nice day, everybody. We'll see you soon. Bye-bye.